FOLFIRI and Sunitinib in Metastatic Colorectal Cancer
NCT00806663
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Colorectal Cancer
Liver Metastases
Interventions
DRUG:
sunitinib added to FOLFIRI
Sponsor
Central European Society for Anticancer Drug Research